Study Title and Description
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab.|
|Author||Budde K., Bosmans JL., Sennesael J., Zeier M., Pisarski P., Schütz M., Fischer W., Neumayer HH., Glander P.|
|Country||Department of Nephrology, Campus Charité Mitte Charité, Universitätsmedizin Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany. email@example.com|
Pubmed ID: 17390741
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.